# Medical and oncology developments in Italy

> Live situation record from CLSTR: https://clstr.news/situations/medical-and-oncology-developments-in-italy
> Updated: 2026-10-16T09:12:10.000Z. Sources: 24. Developments: 2.

Medical congresses and health discussions in Italy have focused on advancements in oncology and women’s health. Early reports highlighted multidisciplinary approaches to breast and prostate cancer care, emphasizing innovation in nuclear medicine, urological surgery, and molecular targeted therapies.

Subsequent discussions at the National Congress of the Intergruppo Melanoma Italiano addressed the rising incidence of melanoma. Experts noted that immunotherapy and genomic profiling have improved 10-year survival rates for metastatic melanoma to over 50%. The integration of artificial intelligence and digital pathology was identified as a way to enhance diagnostic accuracy. Additionally, medical professionals emphasized the importance of prevention, noting that 80% of melanoma cases are linked to solar exposure.

Recent developments in hematology include AIFA approval of a new therapy using belantamab mafodotin for the first recurrence of multiple myeloma, intended to improve life expectancy and quality of life. In gastroenterology, the Frangipane-Bellizzi hospital in Ariano Irpino has implemented an innovative protocol combining durvalumab immunotherapy with FLOT chemotherapy for stomach cancer treatment, following the international MATTERHORN study.

Parallel health discussions also addressed menopause awareness. Data from a Bayer Italia survey conducted by AstraRicerche reveals that despite increasing social openness, 38.1% of women still hide symptoms such as hot flashes and insomnia. Experts warn that these symptoms can lead to cardiovascular risks and decreased productivity, urging women to consult medical professionals rather than enduring them.

## Claims

- More than 12,900 people are diagnosed with melanoma annually in Italy. (corroborated by 2 sources)
- Over 221,000 patients in Italy are currently living with a melanoma diagnosis. (corroborated by 2 sources)
- Melanoma causes approximately 2,500 deaths per year in Italy. (corroborated by 2 sources)
- The five-year survival rate for melanoma in Italy exceeds 90%. (corroborated by 2 sources)
- Artificial intelligence can serve as a specialized co-pilot to support pathologists in diagnosis. (corroborated by 2 sources)

## Timeline

### 2026-10-16: Italy medical experts report advancements in cancer therapies and women's health

Italian medical experts report breakthroughs in melanoma and multiple myeloma treatments, while highlighting the need for AI in diagnostics and increased awareness regarding menopause symptoms.

22 sources. https://clstr.news/cluster/melanoma-cases-in-italy-exceed-12900-annually

### 2026-10-09: Oncology congresses in Italy focus on cancer care innovation

Recent medical congresses in Palermo and Brindisi have highlighted advancements in oncology, focusing on multidisciplinary approaches to breast and prostate cancer treatments.

2 sources. https://clstr.news/cluster/oncology-congresses-in-italy-focus-on-cancer-care-innovation

---
Cite as: Medical and oncology developments in Italy. CLSTR, https://clstr.news/situations/medical-and-oncology-developments-in-italy